Current portfolio
Arvelle Therapeutics
Dutch biotech company commercializing an epilepsy drug with unprecedented efficacy for refractory patients with partial onset seizures.
- SektorHealthcare
- LandNetherlands
- FondLSP 6
- Entry2019
- Web

- SektorHealthcare
- LandNetherlands
- FondLSP 6
- Entry2019
- Web
